Dephosphorylation of the NPR2 guanylyl cyclase contributes to inhibition of bone growth by fibroblast growth factor

  1. Leia C Shuhaibar  Is a corresponding author
  2. Jerid W Robinson
  3. Giulia Vigone
  4. Ninna P Shuhaibar
  5. Jeremy R Egbert
  6. Valentina Baena
  7. Tracy F Uliasz
  8. Deborah Kaback
  9. Siu-Pok Yee
  10. Robert Feil
  11. Melanie C Fisher
  12. Caroline N Dealy
  13. Lincoln R Potter  Is a corresponding author
  14. Laurinda A Jaffe  Is a corresponding author
  1. University of Connecticut Health Center, United States
  2. University of Minnesota, United States
  3. University of Tübingen, Germany

Abstract

Activating mutations in fibroblast growth factor (FGF) receptor 3 and inactivating mutations in the NPR2 guanylyl cyclase both cause severe short stature, but how these two signaling systems interact to regulate bone growth is poorly understood. Here, we show that bone elongation is increased when NPR2 cannot be dephosphorylated and thus produces more cyclic GMP. By developing an in vivo imaging system to measure cyclic GMP production in intact tibia, we show that FGF-induced dephosphorylation of NPR2 decreases its guanylyl cyclase activity in growth plate chondrocytes in living bone. Thus FGF signaling lowers cyclic GMP production in the growth plate, which counteracts bone elongation. These results define a new component of the signaling network by which activating mutations in the FGF receptor inhibit bone growth.

Article and author information

Author details

  1. Leia C Shuhaibar

    Department of Cell Biology, University of Connecticut Health Center, Farmington, United States
    For correspondence
    shuhaibar@uchc.edu
    Competing interests
    The authors declare that no competing interests exist.
  2. Jerid W Robinson

    Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Giulia Vigone

    Department of Cell Biology, University of Connecticut Health Center, Farmington, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Ninna P Shuhaibar

    Department of Cell Biology, University of Connecticut Health Center, Farmington, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Jeremy R Egbert

    Department of Cell Biology, University of Connecticut Health Center, Farmington, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Valentina Baena

    Department of Cell Biology, University of Connecticut Health Center, Farmington, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Tracy F Uliasz

    Department of Cell Biology, University of Connecticut Health Center, Farmington, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Deborah Kaback

    Department of Cell Biology, University of Connecticut Health Center, Farmington, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Siu-Pok Yee

    Department of Cell Biology, University of Connecticut Health Center, Farmington, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Robert Feil

    Department of Biochemistry, University of Tübingen, Tübingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Melanie C Fisher

    Center for Regenerative Medicine and Skeletal Development, University of Connecticut Health Center, Farmington, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Caroline N Dealy

    Center for Regenerative Medicine and Skeletal Development, University of Connecticut Health Center, Farmington, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Lincoln R Potter

    Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, United States
    For correspondence
    potter@umn.edu
    Competing interests
    The authors declare that no competing interests exist.
  14. Laurinda A Jaffe

    Department of Cell Biology, University of Connecticut Health Center, Farmington, United States
    For correspondence
    ljaffe@uchc.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2636-5721

Funding

Eunice Kennedy Shriver National Institute of Child Health and Human Development (R37HD014939)

  • Laurinda A Jaffe

National Institute of General Medical Sciences (R01GM098309)

  • Lincoln R Potter

National Institute of Diabetes and Digestive and Kidney Diseases (Postdoctoral training grant:T32DK007203)

  • Jerid W Robinson

National Institute of Dental and Craniofacial Research (Postdoctoral training grant:R90DE022526)

  • Ninna P Shuhaibar

Fund for Science (Postdoctoral scholarship (mentor)))

  • Laurinda A Jaffe

Fund for Science (Postdoctoral scholarship (postdoc)))

  • Leia C Shuhaibar

Fund for Science (Research grant)

  • Caroline N Dealy

Fund for Science (Research grant)

  • Lincoln R Potter

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Gail Mandel, Oregon Health & Science University, United States

Ethics

Animal experimentation: All experiments were conducted as approved by the animal care committees of the University of Connecticut Health Center (101395-0519) and the University of Minnesota (1507-32769A).

Version history

  1. Received: September 22, 2017
  2. Accepted: December 2, 2017
  3. Accepted Manuscript published: December 4, 2017 (version 1)
  4. Version of Record published: December 27, 2017 (version 2)

Copyright

© 2017, Shuhaibar et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,730
    views
  • 268
    downloads
  • 25
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Leia C Shuhaibar
  2. Jerid W Robinson
  3. Giulia Vigone
  4. Ninna P Shuhaibar
  5. Jeremy R Egbert
  6. Valentina Baena
  7. Tracy F Uliasz
  8. Deborah Kaback
  9. Siu-Pok Yee
  10. Robert Feil
  11. Melanie C Fisher
  12. Caroline N Dealy
  13. Lincoln R Potter
  14. Laurinda A Jaffe
(2017)
Dephosphorylation of the NPR2 guanylyl cyclase contributes to inhibition of bone growth by fibroblast growth factor
eLife 6:e31343.
https://doi.org/10.7554/eLife.31343

Share this article

https://doi.org/10.7554/eLife.31343

Further reading

    1. Computational and Systems Biology
    2. Developmental Biology
    Gang Xue, Xiaoyi Zhang ... Zhiyuan Li
    Research Article

    Organisms utilize gene regulatory networks (GRN) to make fate decisions, but the regulatory mechanisms of transcription factors (TF) in GRNs are exceedingly intricate. A longstanding question in this field is how these tangled interactions synergistically contribute to decision-making procedures. To comprehensively understand the role of regulatory logic in cell fate decisions, we constructed a logic-incorporated GRN model and examined its behavior under two distinct driving forces (noise-driven and signal-driven). Under the noise-driven mode, we distilled the relationship among fate bias, regulatory logic, and noise profile. Under the signal-driven mode, we bridged regulatory logic and progression-accuracy trade-off, and uncovered distinctive trajectories of reprogramming influenced by logic motifs. In differentiation, we characterized a special logic-dependent priming stage by the solution landscape. Finally, we applied our findings to decipher three biological instances: hematopoiesis, embryogenesis, and trans-differentiation. Orthogonal to the classical analysis of expression profile, we harnessed noise patterns to construct the GRN corresponding to fate transition. Our work presents a generalizable framework for top-down fate-decision studies and a practical approach to the taxonomy of cell fate decisions.

    1. Developmental Biology
    2. Evolutionary Biology
    Zhuqing Wang, Yue Wang ... Wei Yan
    Research Article

    Despite rapid evolution across eutherian mammals, the X-linked MIR-506 family miRNAs are located in a region flanked by two highly conserved protein-coding genes (SLITRK2 and FMR1) on the X chromosome. Intriguingly, these miRNAs are predominantly expressed in the testis, suggesting a potential role in spermatogenesis and male fertility. Here, we report that the X-linked MIR-506 family miRNAs were derived from the MER91C DNA transposons. Selective inactivation of individual miRNAs or clusters caused no discernible defects, but simultaneous ablation of five clusters containing 19 members of the MIR-506 family led to reduced male fertility in mice. Despite normal sperm counts, motility, and morphology, the KO sperm were less competitive than wild-type sperm when subjected to a polyandrous mating scheme. Transcriptomic and bioinformatic analyses revealed that these X-linked MIR-506 family miRNAs, in addition to targeting a set of conserved genes, have more targets that are critical for spermatogenesis and embryonic development during evolution. Our data suggest that the MIR-506 family miRNAs function to enhance sperm competitiveness and reproductive fitness of the male by finetuning gene expression during spermatogenesis.